CTOs on the Move

ZERO - The End of Prostate Cancer

www.zerocancer.org

 
ZERO - The End of Prostate Cancer is a 501 non-profit organization dedicated to prostate cancer education, testing, patient support, research and advocacy.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

HealthQuest Physical Therapy

At HealthQuest Physical Therapy, our team of physical therapist provides personalized physical therapy treatment in Michigan. Schedule a free consult today!

PAT Services

PAT Services is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Share Our Selves

Share Our Selves is a Costa Mesa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mountain Health Network

Mountain Health Network is a West Virginia-based not-for-profit health delivery system comprised of Cabell Huntington Hospital, a 303-bed teaching hospital for Marshall University Schools of Medicine, Pharmacy and Nursing; St. Mary`s Medical Center, a 393-bed teaching hospital that operates St. Mary`s Schools of Nursing, Respiratory Care and Medical Imaging; Hoops Family Children`s Hospital, a 72-bed pediatric specialty hospital within Cabell Huntington Hospital; HIMG, a 60-member multi-specialty physician group; and a management agreement with Pleasant Valley Hospital, a 101 acute-bed hospital. Mountain Health is committed to improving the health and well-being of over one million children and adults in 23 counties in West Virginia, southern Ohio, and eastern Kentucky through understanding, respecting, and meeting their needs.

Intrexon

Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment, and Consumer Sectors to create biologically-based products that improve the quality of life and the health of the planet. Through the company’s proprietary UltraVector® platform and and suite of technologies, Intrexon provides its partners with industrial-scale design and development of complex biological systems. The UltraVector® platform delivers unprecedented control over the quality, function, and performance of living cells. We call our synthetic biology approach and integrated technologies Better DNA®, and we invite you to discover more at www.DNA.com.